Browse by Title

Type here to filter the list

R
(R)TTE analysis: MIDD applications, concept, methodology and NONMEM hands-on, Pharmetheus (PHARM002)
Favorite

Jurgen Langenhorst ### 2343530###Speaker#########
Speaker: Jurgen Langenhorst
### @@@ Felicien Le Louedec, PharmD, PhD – Pharmetheus ### 2343531###Speaker###Associate Consultant###Pharmetheus###
Speaker: Felicien Le Louedec, PharmD, PhD – Pharmetheus
### @@@ Joakim Nyberg, PhD (he/him/his) – Pharmetheus ### 2343532###Speaker###Chief Technology Officer###Pharmetheus###
Speaker: Joakim Nyberg, PhD (he/him/his) – Pharmetheus
### he/him/his @@@ Qing Xi Ooi, PhD (she/her/hers) – Pharmetheus ### 2343533###Speaker###Senior Consultant###Pharmetheus###
Speaker: Qing Xi Ooi, PhD (she/her/hers) – Pharmetheus
### she/her/hers PHARM002
(R)TTE analysis: MIDD applications, concept, methodology and NONMEM hands-on, Pharmetheus (PHARM001)
Favorite

Lena E. Friberg, PhD (she/her/hers) – Uppsala University ### 2343527###Speaker###Professor###Uppsala University###
Speaker: Lena E. Friberg, PhD (she/her/hers) – Uppsala University
### she/her/hers @@@ Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech ### 2343528###Speaker###Senior Director & Distinguished Scientist###Genentech###
Speaker: Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech
### she/her/hers @@@ France Mentre, PhD, MD (she/her/hers) – INSERM / Université Paris Cité ### 2343529###Speaker###Professor of Biostatistics###INSERM / Université Paris Cité###
Speaker: France Mentre, PhD, MD (she/her/hers) – INSERM / Université Paris Cité
### she/her/hers PHARM001
Regulatory Experiences and Considerations for Model-Informed Approaches in Antibody-drug conjugates (ADCs) Drug Development
Favorite

Yangbing Li, PhD – U.S. Food and Drug Administration ### 2408373###Speaker###Senior Reviewer###U.S. Food and Drug Administration###
Speaker: Yangbing Li, PhD – U.S. Food and Drug Administration
###
Regulatory Experiences and Considerations for Model-Informed Approaches to Drug Development in Pregnancy and Lactation
Favorite

Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2360725###Speaker###Clinical Pharmacology Policy Lead ###U.S. Food and Drug Administration###
Speaker: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers
Roller Coaster 1
Favorite

Emmanuel Chigutsa, PhD – Eli Lilly and Company ### 2407572###Moderator###Executive Director###Eli Lilly and Company###
Moderator: Emmanuel Chigutsa, PhD – Eli Lilly and Company
### @@@ Xiling Jiang, PhD – US FDA ### 2380201###Speaker###Master Clinical Pharmacologist###US FDA###
Speaker: Xiling Jiang, PhD – US FDA
### @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Speaker###Professor###University of Maryland###
Speaker: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his @@@ Theodore Lystig, MS, PhD – BridgeBio ### 2384719###Speaker###SVP, Chief Analytics Officer###BridgeBio###
Speaker: Theodore Lystig, MS, PhD – BridgeBio
### @@@ Liping Zhang, PhD (she/her/hers) – Johnson and Johnson ### 2384721###Speaker###Senior Director###Johnson and Johnson###
Speaker: Liping Zhang, PhD (she/her/hers) – Johnson and Johnson
### she/her/hers @@@ Grace V. Lee, PhD (she/her/hers) – Critical Path Institute ### 2384736###Speaker###Quantitative Medicine Scientist###Critical Path Institute###
Speaker: Grace V. Lee, PhD (she/her/hers) – Critical Path Institute
### she/her/hers
Roller Coaster 2
Favorite

Fiona Glassman, PhD (she/her/hers) – Biogen ### 2407570###Moderator###Associate Scientific Director, Clinical Pharmacology###Biogen###
Moderator: Fiona Glassman, PhD (she/her/hers) – Biogen
### she/her/hers @@@ Jin Dong, PhD – AstraZeneca ### 2360675###Speaker###Associate Director###AstraZeneca###
Speaker: Jin Dong, PhD – AstraZeneca
### @@@ Lisl Shoda, PhD (she/her/hers) – Simulations Plus Inc ### 2384737###Speaker###Associate Vice President and Director of Immunology###Simulations Plus Inc###
Speaker: Lisl Shoda, PhD (she/her/hers) – Simulations Plus Inc
### she/her/hers @@@ Fulya Akpinar Singh, PhD (she/her/hers) – Genmab ### 2384739###Speaker###Director###Genmab###
Speaker: Fulya Akpinar Singh, PhD (she/her/hers) – Genmab
### she/her/hers @@@ Colin W. Castleberry, PhD (he/him/his) – Amgen ### 2446207###Speaker###Senior Scientist###Amgen###
Speaker: Colin W. Castleberry, PhD (he/him/his) – Amgen
### he/him/his @@@ Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea ### 2453965###Speaker###Research fellow###Catholic university of Korea###
Speaker: Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea
### she/her/hers
Roller Coaster 3
Favorite

Navin Goyal, PhD – Johnson and Johnson ### 2407901###Moderator###Sr Director, CPP###Johnson and Johnson###
Moderator: Navin Goyal, PhD – Johnson and Johnson
### @@@ Jenny Chien, PhD – Eli Lilly and Company ### 2360687###Speaker###Associate Vice President###Eli Lilly and Company###
Speaker: Jenny Chien, PhD – Eli Lilly and Company
### @@@ Sebastiaan C. Goulooze, PhD (he/him/his) – LAP&P Consultants BV ### 2360665###Speaker###Senior Expert Pharmacometrician###LAP&P Consultants BV###
Speaker: Sebastiaan C. Goulooze, PhD (he/him/his) – LAP&P Consultants BV
### he/him/his @@@ Eleni Caratzas, MSc, PhD – Janssen RnD ### 2384740###Speaker###Senior Scientist ###Janssen RnD ###
Speaker: Eleni Caratzas, MSc, PhD – Janssen RnD
### @@@ Stephan Schmidt, PhD (he/him/his) – University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology ### 2384741###Speaker###Professor and Director CPSP###University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology###
Speaker: Stephan Schmidt, PhD (he/him/his) – University of Florida, Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology
### he/him/his @@@ Ahmed H. Salem, PhD, FCP – Abbvie ### 2384742###Speaker###Senior Research Fellow###Abbvie###
Speaker: Ahmed H. Salem, PhD, FCP – Abbvie
###
Roller Coaster 4 - Birds of a Feather 5
Favorite

Annie Lumen, PhD – Clinical Pharmacology Modeling & Simulation, Amgen ### 2407902###Moderator###Senior Principal Scientist###Clinical Pharmacology Modeling & Simulation, Amgen###
Moderator: Annie Lumen, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
### @@@ Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen ### 2384744###Speaker###Principal Scientist###Clinical Pharmacology Modeling & Simulation, Amgen###
Speaker: Xinwen Zhang, PhD – Clinical Pharmacology Modeling & Simulation, Amgen
### @@@ Vincent Hurez, DVM, PhD (he/him/his) – Regeneron Pharmaceuticals Inc. ### 2487145###Speaker###Director Group Quantitative Pharmacology###Regeneron Pharmaceuticals Inc.###
Speaker: Vincent Hurez, DVM, PhD (he/him/his) – Regeneron Pharmaceuticals Inc.
### he/him/his @@@ John C. Panetta, PhD (he/him/his) – St Jude Children's Research Hospital ### 2384747###Speaker###Biomedical Modeler###St Jude Children's Research Hospital###
Speaker: John C. Panetta, PhD (he/him/his) – St Jude Children's Research Hospital
### he/him/his @@@ Wilhelmus E.A. De Witte, PhD – ESQlabs ### 2343519###Speaker###Lead Large Molecule Platform - Principal Scientist###ESQlabs###
Speaker: Wilhelmus E.A. De Witte, PhD – ESQlabs
### @@@ Zackary R. Kenz, PhD – Simulations Plus ### 2453910###Speaker###Principal Scientist###Simulations Plus###
Speaker: Zackary R. Kenz, PhD – Simulations Plus
###